NCT04755348View on ClinicalTrials.gov

A Study to Assess the Pharmacokinetics of Oral Nicotine Pouches and Lozenges in Healthy Adults

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

February 18, 2021

Primary Completion Date

March 20, 2021

Study Completion Date

March 25, 2021

Conditions
Tobacco UseTobacco SmokingCigarette Smoking
Interventions
OTHER

Product A

A 4mg nicotine pouch product

OTHER

Product B

A 4mg nicotine pouch product

OTHER

Product C

A 2mg nicotine lozenge product

OTHER

Product D

A 2mg nicotine lozenge product

OTHER

Product E

A 2mg nicotine lozenge product

OTHER

Product F

A 2mg nicotine lozenge product

Trial Locations (1)

66212

Altasciences Clinical Kansas, Inc., Overland Park

All Listed Sponsors
lead

British American Tobacco (Investments) Limited

INDUSTRY

NCT04755348 - A Study to Assess the Pharmacokinetics of Oral Nicotine Pouches and Lozenges in Healthy Adults | Biotech Hunter | Biotech Hunter